- Home
- VANI vs FISI Comparison
VANI vs FISI Comparison
Compare VANI & FISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- FISI
- Stock Information
- Founded
- VANI 1998
- FISI 1817
- Country
- VANI United States
- FISI United States
- Employees
- VANI N/A
- FISI N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- FISI Major Banks
- Sector
- VANI Health Care
- FISI Finance
- Exchange
- VANI Nasdaq
- FISI Nasdaq
- Market Cap
- VANI 68.1M
- FISI N/A
- IPO Year
- VANI 2014
- FISI 1999
- Fundamental
- Price
- VANI $1.26
- FISI $25.82
- Analyst Decision
- VANI Strong Buy
- FISI Buy
- Analyst Count
- VANI 1
- FISI 3
- Target Price
- VANI $4.00
- FISI $33.00
- AVG Volume (30 Days)
- VANI 66.4K
- FISI 91.5K
- Earning Date
- VANI 05-13-2025
- FISI 07-24-2025
- Dividend Yield
- VANI N/A
- FISI 4.80%
- EPS Growth
- VANI N/A
- FISI N/A
- EPS
- VANI N/A
- FISI N/A
- Revenue
- VANI N/A
- FISI $108,628,000.00
- Revenue This Year
- VANI N/A
- FISI $101.16
- Revenue Next Year
- VANI N/A
- FISI $6.68
- P/E Ratio
- VANI N/A
- FISI N/A
- Revenue Growth
- VANI N/A
- FISI N/A
- 52 Week Low
- VANI $0.91
- FISI $16.81
- 52 Week High
- VANI $2.09
- FISI $29.79
- Technical
- Relative Strength Index (RSI)
- VANI 77.37
- FISI 51.06
- Support Level
- VANI $1.13
- FISI $25.50
- Resistance Level
- VANI $1.16
- FISI $26.20
- Average True Range (ATR)
- VANI 0.05
- FISI 0.58
- MACD
- VANI 0.02
- FISI -0.17
- Stochastic Oscillator
- VANI 92.86
- FISI 25.43
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.